MedDEV Inc

MedDEV has patented and developed a homeopathic topical disc to treat all of the core symptoms of autism spectrum disorders.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Stanwood, WA, USA
  • Currency USD
  • Founded July 2006
  • Employees 0
  • Incorporation Type C-corp
  • Website respen-a.com

Company Summary

MedDEV is a privately held startup biotech company. The company's focus is to develop new treatments for neurological conditions, specifically those related to mitochondrial dysfunction. MedDEV has been issued patents in the US and Europe for depression, bipolar disorder, multiple sclerosis, autism spectrum disorders and Alzheimer's disease.

MedDEV is bringing Respen-A, a homeopathic treatment for the symptoms of autism to the OTC market.

Team

  • Elaine DeLack
    CEO and Chairman

    Elaine DeLack, RN is the founder of MedDEV, Inc. (established in 2006), and EDMS LLC (established in 1998). She has developed and patented treatments for multiple sclerosis, depression, bipolar disorder, and autism spectrum disorder. Her theoretical and research study results for multiple sclerosis have been published in the scientific journals, Multiple Sclerosis Clinical and Laboratory Research, and the Alternative Medicine Review.

Advisors

Previous Investors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free